DJS Law Group reminds investors about PROCEPT BioRobotics securities class action

DJS Law Group said in a Sept. 8, 2026, PR Newswire release that it is reminding investors about a class action lawsuit against PROCEPT BioRobotics Corporation, the medical device company that trades on Nasdaq as PRCT.

The release says the case alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. It identifies a class period of Feb. 28, 2024, through Feb. 25, 2026.

Why it matters

The filing notice targets investors who bought PROCEPT shares during the stated class period. The release says shareholders can contact the firm about possible lead plaintiff appointments, and that lead plaintiff status is not required to recover in any future proceeding.

Because the source is a law-firm press release describing allegations, the claims should be treated as accusations, not findings. The release does not provide a court case number, filing court, judge, settlement amount, or any response from PROCEPT BioRobotics.

Background

According to the release’s summary of the complaint, the plaintiffs allege the company made false and misleading statements to the market. The release says those statements inflated revenue by using aggressive discounting to pull sales forward from future periods and created a glut of inventory in the market.

The release also says the company is referred to as Procept or the Company. It does not say whether the firm has responded publicly to the complaint.

What happens next

The release directs shareholders who purchased shares during the class period to contact DJS Law Group regarding possible lead plaintiff appointments. No other deadlines or court milestones were included in the source.

Sources

• PR Newswire release, Sept. 8, 2026

Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.